...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: VP of clinical operations

Looking at Lisa Bauman LinkedIn account still lists her as an employee of Zenith Epigenetics as of today , not sure if she was ever on the Zenith website management listingĀ 

Share
New Message
Please login to post a reply